[Translation] A single-center, randomized, open-label, two-dose, single-dose, four-period, completely repeated crossover, fasting/fed bioequivalence study of diclofenac sodium extended-release tablets in healthy study participants
以药代动力学参数作为主要终点评价指标,分别比较在空腹/餐后条件下口服受试制剂双氯芬酸钠缓释片(规格:100mg,生产厂家:津药达仁堂集团股份有限公司新新制药厂)与参比制剂双氯芬酸钠缓释片(规格:100mg,持证商:NOVARTIS PHARMA S.A.S.,商品名:Voltarene LP®)在健康研究参与者体内的药代动力学行为,评价两种制剂的生物等效性。
[Translation] Using pharmacokinetic parameters as the primary endpoint evaluation indicators, the pharmacokinetic behavior of the test preparation diclofenac sodium sustained-release tablets (specification: 100 mg, manufacturer: Xinxin Pharmaceutical Factory of Tianjin Darentang Group Co., Ltd.) and the reference preparation diclofenac sodium sustained-release tablets (specification: 100 mg, licensee: NOVARTIS PHARMA S.A.S., trade name: Voltarene LP®) in healthy study participants after oral administration under fasting/postprandial conditions was compared to evaluate the bioequivalence of the two preparations.